238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.66%
Revenue growth under 50% of BIDU's 47.95%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
0.69%
Gross profit growth under 50% of BIDU's 60.93%. Michael Burry would be concerned about a severe competitive disadvantage.
-4.94%
Negative EBIT growth while BIDU is at 83.07%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.94%
Negative operating income growth while BIDU is at 83.07%. Joel Greenblatt would press for urgent turnaround measures.
-5.88%
Negative net income growth while BIDU stands at 74.26%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-6.67%
Negative EPS growth while BIDU is at 76.47%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-6.67%
Negative diluted EPS growth while BIDU is at 76.47%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.14%
Share count expansion well above BIDU's 0.08%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-0.04%
Reduced diluted shares while BIDU is at 0.05%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-19.31%
Negative OCF growth while BIDU is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-31.39%
Negative FCF growth while BIDU is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
5879.45%
Similar 10Y revenue/share CAGR to BIDU's 5428.75%. Walter Schloss might see both firms benefiting from the same long-term demand.
318.91%
5Y revenue/share CAGR under 50% of BIDU's 2173.78%. Michael Burry would suspect a significant competitive gap or product weakness.
71.76%
3Y revenue/share CAGR under 50% of BIDU's 365.29%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
183.87%
OCF/share CAGR of 183.87% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
65.31%
3Y OCF/share CAGR of 65.31% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
7396.75%
Net income/share CAGR at 50-75% of BIDU's 11153.78%. Martin Whitman might question if the firm’s product or cost base lags behind.
356.45%
Below 50% of BIDU's 5651.51%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
93.95%
Below 50% of BIDU's 475.52%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
773.52%
Below 50% of BIDU's 18246.82%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
101.45%
Below 50% of BIDU's 273.54%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
17.28%
AR growth well above BIDU's 29.40%. Michael Burry fears inflated revenue or higher default risk in the near future.
-83.46%
Inventory is declining while BIDU stands at 42.45%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
12.07%
Asset growth at 50-75% of BIDU's 18.60%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
5.93%
Under 50% of BIDU's 16.28%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
9.78%
R&D dropping or stable vs. BIDU's 30.41%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
7.18%
SG&A declining or stable vs. BIDU's 23.51%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.